Last10K.com

La Jolla Pharmaceutical Co (LJPC) SEC Filing 10-K Annual report for the fiscal year ending Sunday, December 31, 2017

La Jolla Pharmaceutical Co

CIK: 920465 Ticker: LJPC
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2017
Feb. 16, 2018
Jun. 30, 2017
Document And Entity Information [Abstract]   
Entity Registrant NameLA JOLLA PHARMACEUTICAL CO  
Entity Central Index Key0000920465  
Document Type10-K  
Document Period End DateDec. 31, 2017  
Amendment Flagfalse  
Document Fiscal Year Focus2017  
Document Fiscal Period FocusFY  
Current Fiscal Year End Date--12-31  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Filer CategoryAccelerated Filer  
Entity Public Float  $ 512,864,000
Entity Common Stock, Shares Outstanding 22,168,242 

View differences made from one year to another to evaluate La Jolla Pharmaceutical Co's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by La Jolla Pharmaceutical Co.

Continue

Assess how La Jolla Pharmaceutical Co's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

La Jolla Pharmaceutical Co's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Financial
Other
Filter by Subcategory:
All
Expense
Shares
Cash Flow
Other
Inside La Jolla Pharmaceutical Co's 10-K Annual Report:

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Shareholders' Equity
Balance Sheet Account Details
Balance Sheet Account Details (accrued Expenses) (details)
Balance Sheet Account Details (property And Equipment) (details)
Balance Sheet Account Details (tables)
Business
Business (details)
Commitments And Contingencies
Commitments And Contingencies (annual Future Minimum Licensing Payments) (details)
Commitments And Contingencies (annual Future Minimum Payments For Manufacturing And Supply Agreements) (details)
Commitments And Contingencies (annual Future Minimum Payments Under Operating Leases) (details)
Commitments And Contingencies (narrative) (details)
Commitments And Contingencies (tables)
Contract Revenue - Related Party (narrative) (details)
Contract Revenue - Related Party (notes)
Defined Contribution Plan
Defined Contribution Plan (narrative) (details)
Income Taxes
Income Taxes (narrative) (details)
Income Taxes (provision For Income Taxes) (details)
Income Taxes (significant Components Of Deferred Tax Assets) (details)
Income Taxes (tables)
Licensed Technology
Licensed Technology (narrative) (details)
Quarterly Financial Information (unaudited)
Quarterly Financial Information (unaudited) (details)
Quarterly Financial Information (unaudited) (tables)
Shareholders??? Equity
Shareholders??? Equity (narrative) (details)
Shareholders??? Equity (share-based Compensation Expense) (details)
Shareholders??? Equity (stock Option And Restricted Stock Award Activity) (details)
Shareholders??? Equity (stock Options, Valuation Assumptions) (details)
Shareholders??? Equity (summary Of Restricted Stock Awards) (details)
Shareholders??? Equity (tables)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (narrative) (details)
Summary Of Significant Accounting Policies (policies)
Ticker: LJPC
CIK: 920465
Form Type: 10-K Annual Report
Accession Number: 0000920465-18-000007
Submitted to the SEC: Thu Feb 22 2018 4:52:46 PM EST
Accepted by the SEC: Thu Feb 22 2018
Period: Sunday, December 31, 2017
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/ljpc/0000920465-18-000007.htm